# The Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning Dosing

> **NCT00609895** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 22 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** INSULIN GLARGINE

## Key facts

- **NCT ID:** NCT00609895
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2008-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00609895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00609895, "The Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning Dosing". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00609895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*